Insulin glargine (Mylan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Insulin glargine (Mylan), covering 2020-09-14 to 2020-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients [Phase 3]